2CARE4 ApS

CVR28964080

Core data

Name
2CARE4 ApS
Address
Stenhuggervej 12, 6710, Esbjerg V
Founded
Aug 5, 2005
207 / 167
Locations (P-units)
2View locations
Website
https://www.2care4.dk/
Branch
Engroshandel med medicinalvarer og sygeplejeartikler (464610)

Keep track of 2CARE4 ApS

Get an email when we detect changes to financial reports, ownership, management or property trades. Save yourself checking the company again.
Free account

Description

2care4 is a pharmaceutical company founded in 2005 with solid experience in parallel importing medicinal products for human medicine within EU/EEA countries. It supplies medicines to Scandinavian markets and operates from headquarters in Esbjerg.

2care4 parallel-imports medicinal products for human medicine and develops and trades generic medicines. The group focuses on the Nordic and German pharmaceutical markets.

Products & services

Parallel import of medicinal products · Generic medicine development · Trading of generic medicines · Information about medicines and preparations

Industries

Pharmaceuticals · Parallel import of medicinal products · Generic medicines

Customer types

Pharmaceutical wholesalers · Suppliers and business partners

Analysis by AI ✨

2care4’s revenue rose from DKK 1,206 million in 2023 to DKK 1,230 million in 2024, while profit after tax fell from DKK 48.8 million to DKK 20.3 million. Equity stood at DKK 100.1 million at year-end 2024. The annual report describes the company’s main activities as sales of parallel-imported medicines and generic medicines; it also notes an increased focus on product development.

In July 2026, the company had 196 employees and 159 full-time equivalents (FTE). In July 2025, the corresponding figures were 181 employees and 143 FTE.

2care4 Group ApS owns 100% of 2care4 ApS. HØJFELDT HOLDING ApS owns 50–66.66% of 2care4 Group ApS, and TV HOLDING ApS also owns 50–66.66%.

AI-generated texts are based on registered information, which may be delayed or incomplete. Errors may occur.

Financials

Company financials
Reporting period
2024DKKOpen PDF
Revenue
1,230,471,000
Gross profit
136,277,000
Operating profit
40,602,000
Profit before tax
26,168,000
Net income
20,347,000
Total assets
529,095,000
Equity
100,082,000
Avg. employees
158
2017–2024

Unlock financial history

Datapublica Risk Score

Locked
Assesses the risk of financial distress using the company’s accounts, history, and connections.
Company score
0 · Low100 · High

What goes into the assessment

  • Financials

  • Accounts and history

  • Owners and management

  • Company and connections

Standard: Score and risk bandPro: Also a detailed explanation of the factors

Contact

From cvr.dk

Company
7515****Show full

From 2care4.dk

Main
+45 75 15 ** **Show full
+45 76 10 ** **Show full
in**@2care4.dkShow full
Børsen Gazelle no. 12011Børsen Gazelle

Candidate 2026 — one financial year missing

Revenue must be at least 2,327,138,000 DKK in the financial year ending Dec 31, 2025.

Børsen Gazelle is Dagbladet Børsen's award. Datapublica is not affiliated with Børsen. Calculated statuses are Datapublica's own analysis of public CVR financial-statement data.

People

Erik SandbergRoles
Board
TitlesFORMAND
Toke VærndalRoles
Board
TitlesBESTYRELSESMEDLEM
Thomas Hørslev HedegaardRoles
Management
TitlesADM. DIR.
Ulrik Kronborg MarkussenRoles
Management
TitlesDIREKTØR

Auditor

PricewaterhouseCoopers Statsautoriseret RevisionspartnerselskabAuditorPalle H. JensenRoleState Authorised Public AccountantFromApr 23, 2025
—AuditorStefan DraceaRoleState Authorised Public AccountantFromApr 23, 2025